Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
US5906987A · kind A · utility
17Cited by
2References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 10, 1997 |
| Grant date | May 25, 1999 |
| Priority date | — |
| Expiry date | Mar 10, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The symptoms of climacterium in male mammals, e.g., hypertension, cardiovascular disease and osteoporosis, are ameliorated by the administration to an afflicted individual one or both of a nitric oxide substrate and/or nitric acid donor, in combination with an androgen, an aromatase inhibitor or both, wherein the circulating levels of testosterone in the afflicted individual are increased.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.